Chemomab Therapeutics Financial Overview
Chemomab Therapeutics's market cap is currently $11.69M. The company's EPS TTM is $-0.016; its P/E ratio is -1.02; Chemomab Therapeutics is scheduled to report earnings on November 20, 2025, and the estimated EPS forecast is $-0.04. See an overview of income statement, balance sheet, and cash flow financials.
